<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=4423596&amp;fmt=gif">
Discover AGCellerate for LVV - a faster option to get your GMP-ready lentiviral vector product   Learn about AGCellerate

2 min read

Bio Asia Taiwan, July 26-30

Bio Asia Taiwan, July 26-30

Date: July 26 - 30, 2023

Location: Taipei Nangang Exhibition Center, Hall 1

Booth: L623

Event Website: https://expo.bioasiataiwan.com/

Ayako Kashima will be presenting at the event

Don't miss our presentation as part of the Regional Collaboration Forum on "How CDMO services are evolving to meet rapidly advancing markets" on July 27 at 14:45 in room 404.

MEET OUR TEAM AND LEARN ABOUT AGC BIOLOGICS

Meet with us during the event to discuss how our global network and capabilities can bring your product to the next step.

Click the link above to get all the details. 

 

REQUEST A MEETING

You can also reach out directly to our experts attending the show

Shigeru Kunii
Sr. Director, Business Development
Email  me
Ayako Kashima
Director, Business Development
Email  me

LEARN ABOUT OUR protein-based biologics and advanced therapies

Mammalian Bioprocessing Systems

We have several decades of experience with mammalian-based bioprocessing production, and can support your project from cell line development through full-scale commercialization. We offer a variety of flexible single-use manufacturing scales with options for multiple configurations at our sites in the U.S., Europe, and Japan, and have large-scale commercial capabilities using  stainless steel reactors at our site in Boulder, CO, USA.

Learn more about our mammalian services

Microbial Bioprocessing Systems

We have produced 100+ products using microbial expressed proteins and multiple modes of expression - including secretion (yeast), periplasmic secretion, soluble intracellular expression, and inclusion bodies, also from initial development through full-scale.  commercialization. Our expertise includes experience with E. coli, Pichia, Pseudomonas Fluorescens, Bacillus microbial expression systems, and more.

We use standard industry systems, including batch and fed-batch methods, to produce microbial drug products, and offer cell banking services that meet the standards of regulatory agencies worldwide, and flexible manufacturing scales to support any stage of your product lifecycle. 

Learn more about our microbial services

Cell Therapy Production and Manufacturing

AGC Biologics’ cell therapy services support every stage of the product journey, from pre-clinical through commercialization. At our Milan and Longmont facilities, we can work with virtually any cell type – including Human Mesenchymal Stem Cells (hMSCs), Exosomes, CD34+, T-Cells, NK Cells, and more.  

Using the latest autologous and allogeneic methods, we help your products meet the exact specifications for patients in a clinical or commercial setting. 

Learn more about our overall cell therapy offering 

Viral Vector Production and Manufacturing 

AGC Biologics scientists have two decades of viral vector-based gene therapy expertise and specialize in adeno-associated viral vectors (AAV), lentiviral vectors (LVV), and retroviral vectors (RVV). Our sites in the U.S. and Italy have supported four commercial products. 

Our ready-to-use platform capabilities for AAV and LVV programs are built on cell factories and bioreactors using adherent and suspension processes, designed entirely in-house. 

Discover more about our viral vector services 

Plasmid DNA (pDNA) Materials 

To support your pDNA needs, AGC Biologics utilizes a customized process based on your specific plasmid and hosting system. We have extensive technical expertise in fermentation, purification, and analytics, and our highly experienced teams routinely manufacture GMP-grade pDNA materials. This work includes starting material for gene therapy, and viral vector manufacturing. 

Learn more about our Plasmid offering

mRNA Manufacturing

AGC Biologics leveraged its 25+ years of experience in microbial, drug substance, and pDNA manufacturing to create our Messenger RNA (mRNA) service line. We manufacture high-quality mRNA in R&D and GMP grades for some of the most demanding applications in the industry today, and offer customized process development services based on your specific mRNA and host system needs.

Learn more about our mRNA services

Download our factsheet

 

Fill out the form below to request a meeting during the event

 

ESGCT 30th Annual Congress, October 24-27

ESGCT 30th Annual Congress, October 24-27

CPHI Barcelona, October 24-26

CPHI Barcelona, October 24-26

BioJapan, October 11-13

BioJapan, October 11-13